Ultra Clean Holdings Inc. (UCTT) Jumps 14.71% on January 12

Equities Staff |

Ultra Clean Holdings Inc. (UCTT) was among the biggest gainers on the Russell 2000 for Tuesday January 12 as the stock popped 14.71% to $5.46, representing a gain of $0.7 per share. Some 243,374 shares traded hands on 1,415 trades, compared with an average daily volume of 185,697 shares out of a total float of 32.25 million. The stock opened at $5.30 and traded with an intraday range of $5.72 to $5.30.

After today's gains, Ultra Clean Holdings Inc. reached a market cap of $176.11 million. Ultra Clean Holdings Inc. has had a trading range between $10.29 and $4.60 over the last year, and it had a 50-day SMA of $5.04 and a 200-day SMA of $6.06.

The stock has a P/E Ratio of 17.

Ultra Clean Holdings Inc develops and supplies critical subsystems for the semiconductor capital equipment industry.

Ultra Clean Holdings Inc. is based out of Hayward, CA and has some 1,546 employees. Its CEO is James P. Scholhamer.

For a complete fundamental analysis analysis of Ultra Clean Holdings Inc., check out Equities.com’s Stock Valuation Analysis report for UCTT. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets


Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…